Drug comparison
Tamsulosin and finasteride are not competing versions of the same medicine.
One relaxes smooth muscle to improve urinary flow symptoms; the other reduces conversion of testosterone to dihydrotestosterone and is used when prostate enlargement makes that strategy relevant.
Direct answer: Tamsulosin is usually discussed when symptom relief is the immediate goal. Finasteride is generally a longer-horizon option for men with an enlarged prostate and requires attention to PSA interpretation. Some patients may be considered for combination therapy rather than an either/or choice.
| Decision factor | Tamsulosin | Finasteride |
|---|---|---|
| Class | Alpha-1 blocker | 5-alpha-reductase inhibitor |
| Main role | Reduce dynamic smooth-muscle resistance and improve lower urinary tract symptoms. | Reduce DHT-driven prostate growth in appropriate men with enlargement. |
| Time horizon | Discussed as the faster symptom-focused option. | Benefit develops over months rather than days. |
| Prostate size requirement | Not selected primarily to shrink the prostate. | Enlargement is a central selection factor. |
| Key tradeoffs | Dizziness, orthostatic symptoms, ejaculation changes and eye-surgery considerations. | Sexual adverse effects, breast changes, mood-related warnings in labeling and PSA interpretation. |
| PSA | Not used to create the characteristic 5-ARI suppression issue. | Labeling describes substantial PSA reduction; clinicians must know the patient is taking it. |
Why prostate size changes the answer
Finasteride’s BPH role is tied to prostate enlargement rather than urinary symptoms alone. Symptoms and size do not always move together: a person can have bothersome symptoms without a markedly enlarged gland, or enlargement with limited bother. A comparison therefore needs more than an online symptom description.
Why onset matters
Someone seeking near-term symptom improvement may have different priorities from someone focused on longer-term progression risk. Finasteride is not a fast substitute for an alpha blocker. Conversely, tamsulosin does not provide the same prostate-size effect as a 5-alpha-reductase inhibitor. If both goals matter, a clinician may discuss combination therapy where appropriate.
Sexual effects must be separated
Tamsulosin labeling includes ejaculation-related effects. Finasteride labeling includes sexual adverse effects involving libido, erection and ejaculation. These outcomes are not interchangeable, and an individual may value them differently. Baseline function, other medicines and health conditions also matter.
PSA is a safety-critical difference
Finasteride can lower PSA values, so the clinician interpreting a result needs to know the medicine, duration and prior values. This page does not provide a do-it-yourself correction formula. A new rise from the lowest observed value can matter even if a number appears within a conventional range, and interpretation belongs with a clinician. A dedicated 5-ARI and PSA decision page is planned for the later PSA phase but is not yet published.
Prescriber checklist
- Is prostate enlargement documented, and how?
- Is the priority faster symptom relief, progression reduction or both?
- What are the baseline blood-pressure and sexual-function concerns?
- How will symptoms and adverse effects be reassessed?
- How should PSA results be interpreted and tracked after starting a 5-ARI?
- Would combination therapy add enough benefit to justify added risks and burden?
Common questions
Which works faster?
Tamsulosin is the more immediate symptom-focused class; finasteride’s benefit develops over a longer period.
Which shrinks the prostate?
Finasteride is the 5-alpha-reductase inhibitor used for that treatment strategy in appropriate men with enlargement.
Can the two be taken together?
Combination therapy is used in selected patients, but this page cannot determine suitability.
Which has fewer sexual side effects?
The types differ and individual experience varies. Compare ejaculation, erection and libido separately with the prescriber.
Does tamsulosin affect PSA like finasteride?
The major PSA-interpretation issue in this comparison is finasteride’s 5-ARI effect.
Can I switch because one is cheaper?
Price matters, but the drugs do different jobs. Do not switch without a prescribing discussion.
What if finasteride seems slow?
Its expected time horizon is different; ask when benefit should be reassessed rather than changing it alone.
Do either replace evaluation?
No. Lower urinary tract symptoms can have other causes and red flags require assessment.